Mike Saxton
Rapt Therapeutics (United States)(US)
Publications by Year
Research Areas
Galectins and Cancer Biology, Monoclonal and Polyclonal Antibodies Research, Macrophage Migration Inhibitory Factor, CAR-T cell therapy research, Phagocytosis and Immune Regulation
Most-Cited Works
- → Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses(2016)229 cited
- → Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation(2023)8 cited
- → A view from industry: The foundations of future commercial support and a call for action(2009)5 cited
- → Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia(2024)2 cited
- → A leaders' guide to the swamp of continuing education planning(2006)1 cited
- → Data from Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia(2024)1 cited
- → Supplementary Data 1 from Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia(2024)